Product Information

PREGABALIN 225 MG CAPSULE is a generic product labeled by Westminster Pharmaceuticals LLC, priced at $0.0692 per EA under NDC 69367043009. Its NADAC has been published 43 times since Jan 28, 2026.

FDA first approved this application on Mar 8, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PREGABALIN 225 MG CAPSULE

Pregabalin
$0.0692per EA
DEA Schedule CV

Strength

225 mg/1

NDC

69367043009

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

PREGABALIN

Approval Type

Generic (ANDA)

FDA Application

ANDA212988

FDA Approved

3/8/2022

TE Code

AB

On Market Since

11/17/2025

Price Statistics

The NADAC for PREGABALIN 225 MG CAPSULE has been published 43 times since Jan 28, 2026, and over the history we have for it it has risen 10.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0692 per EA
All-time high$0.0692 (Nov 18, 2026)
All-time low$0.0543 (Jul 22, 2026)
52-week high$0.0692
52-week low$0.0543
Median price$0.0562
Average price$0.0591
Largest weekly change+13.0% (Sep 23, 2026)
Weeks tracked43
Tracking sinceJan 28, 2026

Price History

1W

+1.3%

1M

+9.0%

3M

+23.1%

6M

+24.5%

1Y

N/A

3Y

N/A

5Y

N/A

All

+10.9%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PREGABALIN 225 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 225 MG CAPSULE, manufactured by Westminster Pharmaceuticals LLC, is $0.0692 per EA (NDC 69367043009), effective Nov 18, 2026.

How has the price of PREGABALIN 225 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for PREGABALIN 225 MG CAPSULE has risen 10.9%. It has been tracked across 43 weekly CMS publications since Jan 28, 2026.

What are the highest and lowest recorded NADAC prices for PREGABALIN 225 MG CAPSULE?

Since Jan 28, 2026, the NADAC for PREGABALIN 225 MG CAPSULE has ranged from a low of $0.0543 (Jul 22, 2026) to a high of $0.0692 (Nov 18, 2026), with a median of $0.0562 per EA.

Are there cheaper alternatives to PREGABALIN 225 MG CAPSULE?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PREGABALIN 225 MG CAPSULE, is $0.0609 per EA — about 12% below PREGABALIN 225 MG CAPSULE.

Who manufactures PREGABALIN 225 MG CAPSULE?

PREGABALIN 225 MG CAPSULE (NDC 69367043009) is labeled by Westminster Pharmaceuticals LLC, and CMS classifies it as a generic product.